Kolexia
Lubetzki Catherine Neurologie
Lubetzki Catherine
Neurologie
Hôpital Pitie Salpetriere
Paris, France
254 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Maladies démyélinisantes Sclérose en plaques récurrente-rémittente Neuromyélite optique COVID-19 Sclérose en plaques chronique progressive Inflammation Atrophie

Collaborateurs

Voir plus
Papeix Anne-Caroline
Papeix Anne-Caroline
Fondation Adolphe de Rothschild, Paris, France
Maillart Elisabeth
Maillart Elisabeth
Hôpital Pitie Salpetriere, Paris, France
Stankoff Bruno
Stankoff Bruno
Hôpital Tenon, Paris, France
Louapre Celine
Louapre Celine
Hôpital Pitie Salpetriere, Paris, France

Industries

Voir plus
Ipsen
4 collaboration(s)
Dernière en 2020
Merck-Serono
4 collaboration(s)
Dernière en 2023
Roche
4 collaboration(s)
Dernière en 2023
Biogen
3 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES): Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19
Essai Clinique (Assistance publique – Hôpitaux de Paris)   01 février 2024
RESPONSE: French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort
Essai Clinique (Hospices Civils de Lyon)   25 janvier 2024
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.
Journal of neurology   11 janvier 2024
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks.
Annals of intensive care   08 janvier 2024
Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab.
Multiple sclerosis (Houndmills, Basingstoke, England)   27 octobre 2023
Deleterious functional consequences of perfluoroalkyl substances accumulation into the myelin sheath.
Environment international   20 septembre 2023
Monitoring recovery after CNS demyelination, a novel tool to de-risk pro-remyelinating strategies.
Brain : a journal of neurology   02 juin 2023
A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis.
Journal of neurology   28 mai 2023
NeurofilMS: Serum Neurofilament-light Chain and Glial Fibrillary Acidic Proten (GFAP) Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis
Essai Clinique (CHU Nîmes)   03 mai 2023
New model of multiple sclerosis correlates demyelination with evolution ...
Medical X Press   01 mai 2023